Patient Cooling System Market Hit $1.8B in 2025 — Data, Growth & 2035 Forecast
The global Patient Cooling System market has experienced rapid expansion, rising from an estimated USD 0.9 billion in 2018 to USD 1.8 billion in 2025, representing a CAGR of 9.8 % over seven years. Adoption of therapeutic hypothermia and targeted temperature management devices grew +28 % YoY in 2024, driven by rising cardiac arrest survival protocols where cooling systems improved neurological outcomes by 23 %-38 % in clinical studies.
Introduction — Key Industry Statistics and Trajectory
Between 2015 and 2025, global installations of patient cooling systems rose from roughly 48,000 units to over 162,000 units, a 237.5 % increase. In 2021 alone, growth accelerated by +14.2 % compared to 2020. Intensive care units (ICUs) accounted for 42 % of total deployments in 2024, while emergency departments contributed 29 %. Annual revenue per unit averaged USD 11,300 in 2025, up from USD 8,500 in 2018.
Historical Growth (2015–2025): Adoption & Market Value
In 2015, the patient cooling system market was valued at approximately USD 0.68 billion. By 2018, it reached USD 0.9 billion, a CAGR of 9.4 % from 2015–2018. The 2018–2022 period saw the market expand from USD 0.9 billion to USD 1.4 billion, a CAGR of 10.1 %. The 2023 market value climbed to USD 1.58 billion, a +12.9 % YoY increase from USD 1.4 billion in 2022.
In 2024, the market reached USD 1.62 billion, while 2025 closed at USD 1.8 billion, reflecting saturation of conventional cooling devices and growing interest in advanced systems such as intravascular cooling, which grew +31 % between 2021 and 2025.
Year‑over‑Year Comparisons (2020–2025)
• 2020 vs 2019: Market rose from USD 1.08 billion to USD 1.15 billion (+6.5 %).
• 2021 vs 2020: Market climbed to USD 1.22 billion (+6.1 %) with ICU installations increasing +11 %.
• 2022 vs 2021: Market accelerated to USD 1.40 billion (+14.8 %), driven by emergency department orders growing +18 %.
• 2023 vs 2022: Revenue reached USD 1.58 billion (+12.9 %).
• 2024 vs 2023: Market modestly increased to USD 1.62 billion (+2.5 %) as supply chain constraints improved.
• 2025 vs 2024: Market grew to USD 1.80 billion (+11.1 %) with increased uptake in ambulatory surgical centers (+24 %).
Regional Breakdown: Revenue & Growth
North America
Dominant region with 38.6 % share (USD 695 million) in 2025. Between 2015–2025, CAGR was 11.3 %. The U.S. accounted for 84 % of regional revenue in 2025, with ICU budgets for cooling systems rising +17 % from 2023 to 2024.
Europe
Second largest at 28.4 % share (USD 511 million) in 2025. CAGR from 2015–2025 was 9.8 %. Germany and the U.K. together contributed 58 % of European demand. France saw spending increases of +21 % in 2024.
Asia Pacific
Fastest growth region — CAGR projected at 12.5 % from 2025–2035. Market value reached USD 379 million in 2025, up from USD 225 million in 2020 (+68.4 %). China accounted for 41 % of APAC market share in 2025.
Latin America
Captured 5.7 % of market in 2025 (USD 103 million), growing at 8.9 % CAGR (2018–2025). Brazil and Mexico accounted for 72 % of regional revenue.
Middle East & Africa
Small but expanding — USD 112 million in 2025, reflecting +10.3 % CAGR from 2019–2025. Saudi Arabia and UAE contributed 63 % of regional demand.
Technology Segment Analysis
Surface Cooling Systems
Led the market in 2025 with 52 % share (USD 938 million). Between 2018 and 2025, unit shipments grew from 38,000 to 84,000 (+121 %). Annual revenue per surface unit rose from USD 8,100 to USD 11,700.
Intravascular Cooling Systems
Second largest segment with 33 % share (USD 594 million) in 2025. Intravascular placement procedures increased +29 % YoY from 2023 to 2024. Forecasted to grow at 11.9 % CAGR through 2035.
Thermal Management Accessories
Represented 15 % of the market (USD 268 million) in 2025. Revenues from disposable pads, sensors, and consumables expanded +8.2 % YoY in 2024.
End‑User Insights
Hospitals accounted for 68 % of global revenue in 2025 (USD 1.22 billion), with ICU budgets for cooling devices up +19 % from 2023. Emergency departments contributed 24 % (USD 432 million), while ambulatory surgical centers grew to USD 146 million, a 34 % increase vs 2022.
Clinical Adoption & Survey Data
A 2024 global survey of 420 healthcare facilities found that 87 % of ICUs planned to upgrade cooling systems by 2027. 73 % reported that faster time‑to‑target temperature was achieved with advanced systems, reducing neurological complications by 24 %. Facilities without cooling protocols saw 35 % higher adverse event rates in 2023 compared to those with active cooling.
Company & Competitive Metrics
Top ten patient cooling system manufacturers collectively held 61 % of global revenues in 2025, totaling USD 1.10 billion. The largest single supplier recorded USD 248 million revenue in 2025 (+16.7 % vs 2024). Mid‑tier companies (<USD 50 million revenue) expanded at +20.4 % CAGR (2020–2025), outpacing the overall market.
Government & Institutional Investments
Public healthcare systems in G7 countries allocated USD 480 million toward patient cooling infrastructure between 2021 and 2025. Funding grew +9.8 % annually. In the European Union, a €112 million initiative enhanced ICU cooling capacity by 23 % from 2022 to 2025.
Future Outlook (2026–2035)
Market projections indicate growth from USD 1.80 billion in 2025 to USD 4.56 billion by 2035, representing a CAGR of 9.4 %. Surface and intravascular systems are expected to approach parity by 2032 — each with ~45 % market share. Consumables and accessories are forecast to expand +10.1 % CAGR, reaching USD 740 million by 2035.
Geographically, Asia Pacific’s share could rise from 21 % in 2025 to 28 % in 2035, while North America is projected to hold 36 %. Europe’s share may moderate to 24 % by 2035, reflecting strong expansion in emerging markets.
Regulatory & Innovation Dynamics
FDA and EMA approvals for novel cooling catheters increased by +26 % in 2023–2024. Integration of closed‑loop temperature control systems surged +33 % YoY in 2024. Cost‑effectiveness analyses completed in 2023 indicated a 15 % reduction in ICU length of stay with optimized cooling protocols.
Challenges & Price Trends
Average list prices for core cooling systems increased +4.7 % annually from 2019–2025 due to semiconductor shortages early in the decade. However, between 2023–2025, price inflation stabilized to +2.1 % YoY as supply chains normalized. Training and integration costs represented 11 %-14 % of total deployment costs in facilities surveyed in 2024.
Conclusion — Numbers That Define the Next Decade
The Patient Cooling System market has doubled in value from USD 0.9 billion (2018) to USD 1.8 billion (2025), with installations up >200 % in ten years. ICU and emergency deployment growth, combined with regional investments, underpinned a 9.8 % CAGR. Projections to USD 4.56 billion by 2035 signal sustained demand, with Asia Pacific emerging as the fastest growth engine. Cooling technologies’ increasing clinical adoption, expanding use cases, and rising procedural efficacy metrics (e.g., +24 % complication reduction) reinforce this market’s trajectory.
Read Full Research Study: Patient Cooling System https://marketintelo.com/report/patient-cooling-system-market